Twelve million American adults receive incorrect diagnoses in outpatient settings annually, with women of color bearing a disproportionate burden. Women overall face 20 to 30 percent higher risk of diagnostic errors compared to white men, but the gap widens further for minority women.
An analysis by KFF Health News revealed that women and minorities experience significantly higher rates of mislabeling and misdiagnosis than white male patients. Women of color find their symptoms even more frequently attributed to anxiety, hormones, or weight issues, creating additional barriers to accurate diagnosis.
This pattern of dismissal, often called medical gaslighting, delays critical diagnoses across multiple conditions. Heart disease illustrates the problem starkly—women are 50 percent more likely than men to receive wrong initial diagnoses after heart attacks. The consequences prove devastating when symptoms like fatigue or nausea get mistaken for anxiety rather than cardiac emergencies.
The roots of these disparities run deep. Until the early 1990s, medical research excluded women of childbearing age from drug studies, yet applied findings universally. This created knowledge gaps about how conditions manifest differently in women, particularly women of color.
Unconscious bias compounds the problem. Medical training historically conditioned doctors to associate certain conditions with specific demographics—heart disease with men, emotional issues with women. These assumptions persist in examination rooms today, where rushed appointments and provider interruptions can miss crucial diagnostic clues.
The emotional and financial toll on misdiagnosed women proves substantial, eroding trust in healthcare systems that systematically fail to recognize their legitimate medical concerns.
See: “The most common health misdiagnoses in women—and why they keep happening” (May 1, 2025)
